<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02885350</url>
  </required_header>
  <id_info>
    <org_study_id>§12/19.6.2016/HUS/400/2016</org_study_id>
    <secondary_id>2016-000486-23</secondary_id>
    <nct_id>NCT02885350</nct_id>
  </id_info>
  <brief_title>Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour</brief_title>
  <official_title>Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the analgesic effect of two different opioids (fentanyl and sufentanil) will be&#xD;
      compared when given either intrathecally or epidurally in primiparous parturients during&#xD;
      early phase of the labour.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Maximum Pain During Contraction at 20 Minutes After the Study Drug Delivery</measure>
    <time_frame>20 minutes</time_frame>
    <description>All parturients are to have a pain visual analog scale (VAS - on a 0-100 mm scale) at 80mm or higher before the initial study drug delivery. On this scale 0 mm presents a totally pain free condition while 100 mm presents the worst imaginable pain. The change of maximum pain in millimeters on the VAS scale during the 20 minutes following the study drug delivery will be recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Duration of Labour Analgesia After the Single Dose of Epidural or Intrathecal Opioid</measure>
    <time_frame>The data below report an average duration of time that is typically less than three hours</time_frame>
    <description>The time from the study drug dose to the administration of next epidural bolus, up to five hours. After the study drug dose all parturients wil have epidural catheters in place for subsequent analgesia.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>Spinal fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 micrograms of intrathecally administered fentanyl in single dose. Total volume of intrathecal injection 2 ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural fentanyl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 micrograms of epidurally administered fentanyl in a single dose. Total volume of epidural injection 7 ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spinal sufentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 micrograms of intrathecally administered sufentanil in a single dose. Total volume of intrathecal injection 2 ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural sufentanil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 micrograms of epidurally administered sufentanil in a single dose. Total volume of epidural injection 7 ml.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Spinal analgesia for labour pain</intervention_name>
    <description>Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
    <arm_group_label>Spinal fentanyl</arm_group_label>
    <arm_group_label>Spinal sufentanil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural analgesia for labour pain</intervention_name>
    <description>Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
    <arm_group_label>Epidural fentanyl</arm_group_label>
    <arm_group_label>Epidural sufentanil</arm_group_label>
    <other_name>labor epidural</other_name>
    <other_name>labour epidural</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primiparous parturients&#xD;
&#xD;
          -  In early phase of labour (cervical dilatation at or under 5 cm)&#xD;
&#xD;
          -  No prior opioids by any route of administration within past 120 min&#xD;
&#xD;
          -  Pain at or over 80 mm on 0-100 mm visual analog scale during contraction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy for any of the medications used&#xD;
&#xD;
          -  Contraindications for epidural/spinal analgesia&#xD;
&#xD;
          -  BMI at the time of delivery under 20 or over 35 kg/m2&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antti J Vaananen, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital (Katiloopiston sairaala)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maternity Hospital, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>Uusimaa</state>
        <zip>FI-00610</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <results_reference>
    <citation>Väänänen A, Kuukasjärvi M, Tekay A, Ahonen J. Spinal and epidural sufentanil and fentanyl in early labour. Acta Anaesthesiol Scand. 2019 Nov;63(10):1413-1418. doi: 10.1111/aas.13450. Epub 2019 Jul 23.</citation>
    <PMID>31286476</PMID>
  </results_reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>August 26, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2016</study_first_posted>
  <results_first_submitted>March 31, 2021</results_first_submitted>
  <results_first_submitted_qc>April 28, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 19, 2021</results_first_posted>
  <last_update_submitted>May 27, 2021</last_update_submitted>
  <last_update_submitted_qc>May 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Jouni Ahonen</investigator_full_name>
    <investigator_title>MD, Ph.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 1, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/50/NCT02885350/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Spinal Fentanyl</title>
          <description>20 micrograms of intrathecally administered fentanyl in single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
        </group>
        <group group_id="P2">
          <title>Epidural Fentanyl</title>
          <description>100 micrograms of epidurally administered fentanyl in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
        </group>
        <group group_id="P3">
          <title>Spinal Sufentanil</title>
          <description>5 micrograms of intrathecally administered sufentanil in a single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
        </group>
        <group group_id="P4">
          <title>Epidural Sufentanil</title>
          <description>20 micrograms of epidurally administered sufentanil in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Parturients in active labour</population>
      <group_list>
        <group group_id="B1">
          <title>Spinal Fentanyl</title>
          <description>20 micrograms of intrathecally administered fentanyl in single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
        </group>
        <group group_id="B2">
          <title>Epidural Fentanyl</title>
          <description>100 micrograms of epidurally administered fentanyl in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
        </group>
        <group group_id="B3">
          <title>Spinal Sufentanil</title>
          <description>5 micrograms of intrathecally administered sufentanil in a single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
        </group>
        <group group_id="B4">
          <title>Epidural Sufentanil</title>
          <description>20 micrograms of epidurally administered sufentanil in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="20"/>
            <count group_id="B5" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Finland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pain visual analog scale at 0-100 mm</title>
          <description>A 100 mm visual analog scale (VAS) is used, where 0 mm presents no pain at all and 100 mm presents the worst possible pain.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84" spread="12"/>
                    <measurement group_id="B2" value="87" spread="9"/>
                    <measurement group_id="B3" value="86" spread="8"/>
                    <measurement group_id="B4" value="87" spread="11"/>
                    <measurement group_id="B5" value="86" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change of Maximum Pain During Contraction at 20 Minutes After the Study Drug Delivery</title>
        <description>All parturients are to have a pain visual analog scale (VAS - on a 0-100 mm scale) at 80mm or higher before the initial study drug delivery. On this scale 0 mm presents a totally pain free condition while 100 mm presents the worst imaginable pain. The change of maximum pain in millimeters on the VAS scale during the 20 minutes following the study drug delivery will be recorded.</description>
        <time_frame>20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Spinal Fentanyl</title>
            <description>20 micrograms of intrathecally administered fentanyl in single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
          </group>
          <group group_id="O2">
            <title>Epidural Fentanyl</title>
            <description>100 micrograms of epidurally administered fentanyl in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
          </group>
          <group group_id="O3">
            <title>Spinal Sufentanil</title>
            <description>5 micrograms of intrathecally administered sufentanil in a single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
          </group>
          <group group_id="O4">
            <title>Epidural Sufentanil</title>
            <description>20 micrograms of epidurally administered sufentanil in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Maximum Pain During Contraction at 20 Minutes After the Study Drug Delivery</title>
          <description>All parturients are to have a pain visual analog scale (VAS - on a 0-100 mm scale) at 80mm or higher before the initial study drug delivery. On this scale 0 mm presents a totally pain free condition while 100 mm presents the worst imaginable pain. The change of maximum pain in millimeters on the VAS scale during the 20 minutes following the study drug delivery will be recorded.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="46" upper_limit="74"/>
                    <measurement group_id="O2" value="36" lower_limit="24" upper_limit="47"/>
                    <measurement group_id="O3" value="67" lower_limit="54" upper_limit="81"/>
                    <measurement group_id="O4" value="42" lower_limit="30" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Duration of Labour Analgesia After the Single Dose of Epidural or Intrathecal Opioid</title>
        <description>The time from the study drug dose to the administration of next epidural bolus, up to five hours. After the study drug dose all parturients wil have epidural catheters in place for subsequent analgesia.</description>
        <time_frame>The data below report an average duration of time that is typically less than three hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Spinal Fentanyl</title>
            <description>20 micrograms of intrathecally administered fentanyl in single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
          </group>
          <group group_id="O2">
            <title>Epidural Fentanyl</title>
            <description>100 micrograms of epidurally administered fentanyl in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
          </group>
          <group group_id="O3">
            <title>Spinal Sufentanil</title>
            <description>5 micrograms of intrathecally administered sufentanil in a single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
          </group>
          <group group_id="O4">
            <title>Epidural Sufentanil</title>
            <description>20 micrograms of epidurally administered sufentanil in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
          </group>
        </group_list>
        <measure>
          <title>The Duration of Labour Analgesia After the Single Dose of Epidural or Intrathecal Opioid</title>
          <description>The time from the study drug dose to the administration of next epidural bolus, up to five hours. After the study drug dose all parturients wil have epidural catheters in place for subsequent analgesia.</description>
          <units>min</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="177" lower_limit="121" upper_limit="234"/>
                    <measurement group_id="O2" value="112" lower_limit="80" upper_limit="143"/>
                    <measurement group_id="O3" value="151" lower_limit="111" upper_limit="192"/>
                    <measurement group_id="O4" value="130" lower_limit="93" upper_limit="168"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 minutes</time_frame>
      <desc>The parturient is monitored for 30 minutes after the intervention</desc>
      <group_list>
        <group group_id="E1">
          <title>Spinal Fentanyl</title>
          <description>20 micrograms of intrathecally administered fentanyl in single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
        </group>
        <group group_id="E2">
          <title>Epidural Fentanyl</title>
          <description>100 micrograms of epidurally administered fentanyl in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
        </group>
        <group group_id="E3">
          <title>Spinal Sufentanil</title>
          <description>5 micrograms of intrathecally administered sufentanil in a single dose. Total volume of intrathecal injection 2 ml.&#xD;
Spinal analgesia for labour pain: Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique</description>
        </group>
        <group group_id="E4">
          <title>Epidural Sufentanil</title>
          <description>20 micrograms of epidurally administered sufentanil in a single dose. Total volume of epidural injection 7 ml.&#xD;
Epidural analgesia for labour pain: Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pruritus</sub_title>
                <description>Opioid induced pruritus</description>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="20"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="20"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="20"/>
                <counts group_id="E4" events="8" subjects_affected="8" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No known limitations.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Antti Vaananen</name_or_title>
      <organization>Helsinki University Central hospital/Women's hospital/anaesthesia</organization>
      <phone>358504271850</phone>
      <email>antti.vaananen@hus.fi</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

